{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:31:36Z","timestamp":1790753496977,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Sickle cell disease (SCD) is a hemolytic anemia caused by a point mutation in the \u03b2 globin gene leading to the expression of an abnormal hemoglobin (HbS) that polymerizes under hypoxic conditions driving red cell sickling. Circulating red cells have been extensively characterized in SCD, as their destruction and removal from peripheral blood are the major contributors to anemia. However, few reports showed cellular abnormalities during erythropoiesis in SCD, suggesting that anemia could also be influenced by defects of central origin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>El Hoss <jats:italic toggle=\"yes\">et al.<\/jats:italic> demonstrated ineffective erythropoiesis (IE) in SCD and deciphered the molecular mechanism underlying cell death during the hemoglobin synthesis phase of terminal differentiation. They showed that HbS polymerization induces apoptosis of differentiating erythroblasts and that fetal hemoglobin rescues these cells through its antipolymerization function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>IE is the major cause of anemia in \u03b2-thalassemia patients, and it is generally surmised that it contributes little to anemia of SCD. Recent reports demonstrate the occurrence of IE in SCD patients and show important alterations in the hematopoietic and erythroid niches, both in SCD patients and in the humanized Townes SCD mouse model. This implies that therapeutic strategies initially designed to improve red cell survival in the circulation of SCD patients would also positively impact erythropoiesis and bone marrow cellularity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/moh.0000000000000642","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T02:09:52Z","timestamp":1614391792000},"page":"171-176","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Ineffective erythropoiesis in sickle cell disease: new insights and future implications"],"prefix":"10.1097","volume":"28","author":[{"given":"Wassim","family":"El Nemer","sequence":"first","affiliation":[{"name":"Etablissement Fran\u00e7ais du Sang PACA-Corse"},{"name":"Aix Marseille Univ, EFS, CNRS, ADES, \u2018Biologie des Groupes Sanguins\u2019, Marseille"},{"name":"Laboratoire d\u2019Excellence GR-Ex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auria","family":"Godard","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Excellence GR-Ex"},{"name":"Universit\u00e9 de Paris, UMR_S1134, BIGR, Inserm"},{"name":"Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"El Hoss","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Excellence GR-Ex"},{"name":"Universit\u00e9 de Paris, UMR_S1134, BIGR, Inserm"},{"name":"Institut National de la Transfusion Sanguine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia, a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20250729","first-page":"1","article-title":"Sickle cell disease","volume":"6736","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","article-title":"Sickle cell biomechanics","volume":"12","author":"Barabino","year":"2010","journal-title":"Annu Rev Biomed Eng"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.12786","article-title":"Haemolysis and abnormal haemorheology in sickle cell anaemia","volume":"165","author":"Connes","year":"2014","journal-title":"Br J Haematol"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0140-6736(04)17192-4","article-title":"Sickle-cell disease","volume":"364","author":"Stuart","year":"2004","journal-title":"Lancet"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood.V69.1.296.296","article-title":"Erythroid marrow function in anemic patients","volume":"69","author":"Cazzola","year":"1987","journal-title":"Blood"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archinte.1982.00340150079015","article-title":"Continuous RBC transfusions in a patient with sickle cell disease","volume":"142","author":"Finch","year":"1982","journal-title":"Arch Intern Med"},{"key":"R9-20250729","first-page":"314","article-title":"Sickling of nucleated erythroid precursors from patients with sickle cell anemia","volume":"26","author":"Hasegawa","year":"1998","journal-title":"Exp Hematol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1182\/blood.V94.4.1451","article-title":"Altered hematopoiesis in murine sickle cell disease","volume":"94","author":"Blouin","year":"1999","journal-title":"Blood"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-04-1376","article-title":"Evidence for ineffective erythropoiesis in severe sickle cell disease","volume":"106","author":"Wu","year":"2005","journal-title":"Blood"},{"key":"R12-20250729","article-title":"Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease","author":"El Hoss","year":"2020","journal-title":"Haematologica"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35049577","article-title":"Diversification of haematopoietic stem cells to specific lineages","volume":"1","author":"Orkin","year":"2000","journal-title":"Nat Rev Genet"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V49.6.855.855","article-title":"Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses","volume":"49","author":"Gregory","year":"1977","journal-title":"Blood"},{"key":"R15-20250729","first-page":"1","article-title":"Heme Synthesis in Erythroid Cells","volume":"4","author":"Granick","year":"1964","journal-title":"Prog Hematol"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1182\/blood-2013-01-476390","article-title":"Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"394295","DOI":"10.1155\/2013\/394295","article-title":"Ineffective erythropoiesis in beta -thalassemia","volume":"2013","author":"Ribeil","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MOH.0000000000000231","article-title":"Novel players in beta-thalassemia dyserythropoiesis and new therapeutic strategies","volume":"23","author":"Arlet","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature05378","article-title":"Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1","volume":"445","author":"Ribeil","year":"2007","journal-title":"Nature"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature13614","article-title":"HSP70 sequestration by free alpha-globin promotes ineffective erythropoiesis in beta-thalassaemia","volume":"514","author":"Arlet","year":"2014","journal-title":"Nature"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1084\/jem.20160301","article-title":"PML is a ROS sensor activating p53 upon oxidative stress","volume":"214","author":"Niwa-Kawakita","year":"2017","journal-title":"J Exp Med"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjh.14800","article-title":"Red blood cells free alpha-haemoglobin pool: a biomarker to monitor the beta-thalassemia intermedia variability. The ALPHAPOOL study","volume":"179","author":"Vasseur","year":"2017","journal-title":"Br J Haematol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/S0021-9258(19)85893-3","article-title":"Evidence for a difference in affinities of human hemoglobin beta A and beta S chains for alpha chains","volume":"255","author":"Shaeffer","year":"1980","journal-title":"J Biol Chem"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJM198202043060504","article-title":"Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia","volume":"306","author":"Embury","year":"1982","journal-title":"N Engl J Med"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.168.3.1193","article-title":"Isolation and immunocytochemical characterization of human bone marrow stromal macrophages in hemopoietic clusters","volume":"168","author":"Lee","year":"1988","journal-title":"J Exp Med"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V19.6.635.635","article-title":"Iron metabolism in the bone marrow as seen by electron microscopy: a critical review","volume":"19","author":"Bessis","year":"1962","journal-title":"Blood"},{"key":"R28-20250729","first-page":"387","article-title":"Role of the reticular cells during maturation process of the erythroblast. 3. The fate of phagocytized nucleus","volume":"15","author":"Seki","year":"1965","journal-title":"Acta Pathol Jpn"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ar.1091730111","article-title":"On the expulsion of the erythroid nucleus and its phagocytosis","volume":"173","author":"Skutelsky","year":"1972","journal-title":"Anat Rec"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","article-title":"Oxygen in stem cell biology: a critical component of the stem cell niche","volume":"7","author":"Mohyeldin","year":"2010","journal-title":"Cell Stem Cell"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-7428-3_8","article-title":"Analyzing the formation, morphology, and integrity of Erythroblastic Islands","volume":"1698","author":"Yeo","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.3057","article-title":"CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress","volume":"19","author":"Chow","year":"2013","journal-title":"Nat Med"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nm.3126","article-title":"Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia","volume":"19","author":"Ramos","year":"2013","journal-title":"Nat Med"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1515\/CCLM.2009.340","article-title":"Nucleated red blood cells and soluble transferrin receptor in thalassemia syndromes: relationship with global and ineffective erythropoiesis","volume":"47","author":"Danise","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"R35-20250729","first-page":"500","article-title":"The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions","volume":"5","author":"Rifkind","year":"2014","journal-title":"Front Physiol"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1182\/blood.2019002227","article-title":"Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion","volume":"135","author":"Park","year":"2020","journal-title":"Blood"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/cells9102159","article-title":"Characterization of hematopoiesis in sickle cell disease by prospective isolation of stem and progenitor cells","volume":"9","author":"Tolu","year":"2020","journal-title":"Cells"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.15902","article-title":"Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery","volume":"186","author":"Leonard","year":"2019","journal-title":"Br J Haematol"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2018.20059","article-title":"Association of matched sibling donor hematopoietic stem cell transplantation with transcranial Doppler velocities in children with sickle cell anemia","volume":"321","author":"Bernaudin","year":"2019","journal-title":"JAMA"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.3324\/haematol.2019.216788","article-title":"Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease","volume":"104","author":"Cappelli","year":"2019","journal-title":"Haematologica"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood.V91.12.4472","article-title":"Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease","volume":"91","author":"Maier-Redelsperger","year":"1998","journal-title":"Blood"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2003-05-1738","article-title":"Effects of 5-aza-2\u2019-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease","volume":"102","author":"Saunthararajah","year":"2003","journal-title":"Blood"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3324\/haematol.2018.213462","article-title":"A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease","volume":"105","author":"McArthur","year":"2019","journal-title":"Haematologica"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.omtm.2020.03.015","article-title":"Preclinical evaluation of a novel lentiviral vector driving lineage-specific BCL11A knockdown for sickle cell gene therapy","volume":"17","author":"Brendel","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2018-08-868893","article-title":"A phase 1\/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease","volume":"133","author":"Howard","year":"2019","journal-title":"Blood"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A Phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N Engl J Med"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","article-title":"CRISPR\/Cas9 beta-globin gene targeting in human haematopoietic stem cells","volume":"539","author":"Dever","year":"2016","journal-title":"Nature"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1093\/nar\/gkz475","article-title":"Highly efficient editing of the beta-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease","volume":"47","author":"Park","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["Current Opinion in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOH.0000000000000642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:19:45Z","timestamp":1753823985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOH.0000000000000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/moh.0000000000000642","relation":{},"ISSN":["1065-6251","1531-7048"],"issn-type":[{"value":"1065-6251","type":"print"},{"value":"1531-7048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}